What Is Scrambler Therapy?
Scrambler therapy (also called Calmare or MC-5A) is a non-invasive treatment that uses surface electrodes to deliver electrical impulses that the brain may interpret as non-pain signals. The theory is that it can "retrain" the brain's perception of pain by replacing pain information with normal sensation signals.1
How It Works (Theory)2
- Electrodes placed around painful area
- Delivers specific electrical patterns
- Aims to send "no pain" signals to brain
- May modulate central sensitization
- Different mechanism than TENS
- Exact mechanisms still being studied
Conditions Studied
- Chemotherapy-induced neuropathy
- Postherpetic neuralgia
- Failed back surgery syndrome
- CRPS
- Diabetic neuropathy
- Phantom limb pain
- Chronic post-surgical pain
The Treatment3
- Series of sessions (usually 10-12)
- 45-60 minutes per session
- Daily or near-daily initially
- Surface electrodes (non-invasive)
- Sensation should be comfortable
- No pain during treatment
Research Evidence
- Growing body of research
- Some studies show promising results
- Especially for chemotherapy neuropathy
- Evidence quality still developing
- More research needed
- Not yet mainstream
Potential Benefits
- Non-invasive
- No medications
- Generally well tolerated
- Effects may last after treatment
- Can repeat if needed
Limitations
- Limited availability
- Often not covered by insurance
- Requires multiple sessions
- Not effective for everyone
- Evidence still emerging
- Expensive out-of-pocket
Contraindications
- Pacemakers or implanted devices
- Pregnancy
- Active skin conditions in treatment area
- Certain heart conditions
Finding Treatment
- Specialized pain centers
- Some oncology centers
- Limited number of providers
- Ask about provider experience
References
- Marineo G. Untreatable pain resulting from abdominal cancer: new hope from biophysics? JOP. 2003;4(1):1-10.
- Coyne PJ, Wan W, Dodson P, et al. A trial of Scrambler therapy in the treatment of cancer pain syndromes and chronic chemotherapy-induced peripheral neuropathy. J Pain Palliat Care Pharmacother. 2013;27(4):359-364.
- Smith TJ, Coyne PJ, Parker GL, et al. Pilot trial of a patient-specific cutaneous electrostimulation device (MC5-A Calmare) for chemotherapy-induced peripheral neuropathy. J Pain Symptom Manage. 2010;40(6):883-891.